Hapbee

Adding Hapbee (HAPB) to the Watch List.

Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...
Hea;thLynked, Biotech Stock Review

Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.

Up as much as 417% from where we added it to the Watch List, the Company continues to report increasing revenues while...
ehave, psychedelic stock review

Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine...

GBT (GTCH) Technologies Looking for Strategic Partners.

GBT Has Opened the Doors for Massive Potential in Minimal Infrastructure Communications. There are some Artificial Intelligence rocket-scientists...

Mitesco (MITI) Sets Opening Dates for New Minneapolis Clinics, Additional Sites in Minneapolis and...

MINNEAPOLIS, MN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTCQB:MITI) ("Mitesco" or the "Company"), a leading operator of wellness clinics...

Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch Of Covid Vaccine...

Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental...

Hapbee’s (HAPB) TV Series, to Air Over Syndicated Television Networks.

New to The Street TV and Hapbee Technologies, Inc. Sign Contract for 12 Part TV Series Across Syndicated Television Networks
Mitesco

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.

LIVE QUOTE Original Report: Initiating Coverage...
Hagerty Garage and Social

Private Investor Meetup with Football Star Tim Wright.

Saturday August 6th, Delray Beach Exclusive cocktail hour with Super Bowl Champion and Dome Audio Founder Tim Wright.

Progressive Care (RXMD) Conference Call.

Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022 MIAMI, FL, Nov. 08, 2022...

Latest article

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...